Nancy A. Norton
Known title: DirectorCIK: 0001943956
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
FedEx eyes record-high Q4 delivery prices and expands digital pharma booking. FedEx expects delivery rates to reach record highs in the fourth quarter, according to a TD Cowen/AFS note. The company says its recent freight‑spin strategy has improved performance, though pricing is still relatively high. It also launched a digital booking platform for European cold‑chain pharmaceutical shipments to make the process smoother for customers.
Transaction History
| LDOS | ▲ Buy | Grant | 1,067 | $0 | 5/8/2026 | View on chart |
| FDX | ▲ Buy | Grant | 823 | $0 | 9/29/2025 | View on chart |
| LDOS | ▲ Buy | Grant | 873 | $0 | 5/9/2025 | View on chart |
| FDX | ▲ Buy | Grant | 755 | $0 | 9/23/2024 | View on chart |
| LDOS | ▲ Buy | Grant | 1,204 | $0 | 5/3/2024 | View on chart |
| FDX | ▲ Buy | Grant | 745 | $0 | 9/22/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Leidos wins new defense and health contracts
Leidos Holdings recently secured new contracts for logistics support in the UK and health research for the U.S. Navy. These wins highlight the company's ongoing role in defense and health services. The stock is currently trading well below the average analyst target price, suggesting potential value for some investors.
Leidos wins new defense and health contracts. Leidos Holdings recently secured new contracts for logistics support in the UK and health research for the U.S. Navy. These wins highlight the company's ongoing role in defense and health services. The stock is currently trading well below the average analyst target price, suggesting potential value for some investors.